Initial multicenter experience with a new high-density coloring module: impact for complex atrial arrhythmias interpretation.


Journal

Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing
ISSN: 1572-8595
Titre abrégé: J Interv Card Electrophysiol
Pays: Netherlands
ID NLM: 9708966

Informations de publication

Date de publication:
Mar 2021
Historique:
received: 29 04 2020
accepted: 15 06 2020
pubmed: 6 7 2020
medline: 19 8 2021
entrez: 5 7 2020
Statut: ppublish

Résumé

High-density automated mapping of complex atrial tachycardias (ATs) requires accurate assessment of activation maps. A new local activation display module (HD coloring, Biosense Webster®) provides higher map resolution, a better delineation of potential block reducing color interpolation, and a new propagation display. We evaluated the accuracy of a dedicated local activation display compared with standard algorithm. High-density maps from 10 AT were collected with a multipolar catheter and were displayed with standard activation or HD coloring. Six expert operators retrospectively analyzed activation maps and were asked to define (1) the tachycardia mechanism, (2) ablation target, and (3) level of difficulty to interpret those maps. Using HD coloring, operators were able to reach a correct diagnosis in 93% vs. 63%, p < 0.05 compared to standard activation maps. Time to diagnosis was shorter 1.9 ± 1.0 min vs. 3.9 ± 2.1 min, p < 0.05. Confidence level would have allowed ablation without necessity for entrainment maneuvers in 87% vs. 53%, p < 0.05. Operators would have needed to remap or proceed with multiple entrainments in 3% vs. 13% of cases, p < 0.05. Finally, ablation strategy was more accurately identified in 97% vs. 67%, p < 0.05. Activation mapping with the new HD coloring module allowed a more accurate, reliable, and faster interpretation of complex ATs mechanisms compared to standard activation maps.

Sections du résumé

BACKGROUND BACKGROUND
High-density automated mapping of complex atrial tachycardias (ATs) requires accurate assessment of activation maps. A new local activation display module (HD coloring, Biosense Webster®) provides higher map resolution, a better delineation of potential block reducing color interpolation, and a new propagation display. We evaluated the accuracy of a dedicated local activation display compared with standard algorithm.
METHODS METHODS
High-density maps from 10 AT were collected with a multipolar catheter and were displayed with standard activation or HD coloring. Six expert operators retrospectively analyzed activation maps and were asked to define (1) the tachycardia mechanism, (2) ablation target, and (3) level of difficulty to interpret those maps.
RESULTS RESULTS
Using HD coloring, operators were able to reach a correct diagnosis in 93% vs. 63%, p < 0.05 compared to standard activation maps. Time to diagnosis was shorter 1.9 ± 1.0 min vs. 3.9 ± 2.1 min, p < 0.05. Confidence level would have allowed ablation without necessity for entrainment maneuvers in 87% vs. 53%, p < 0.05. Operators would have needed to remap or proceed with multiple entrainments in 3% vs. 13% of cases, p < 0.05. Finally, ablation strategy was more accurately identified in 97% vs. 67%, p < 0.05.
CONCLUSION CONCLUSIONS
Activation mapping with the new HD coloring module allowed a more accurate, reliable, and faster interpretation of complex ATs mechanisms compared to standard activation maps.

Identifiants

pubmed: 32621214
doi: 10.1007/s10840-020-00802-1
pii: 10.1007/s10840-020-00802-1
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

313-319

Références

Durrer D, Roos JP. Epicardial excitation of the ventricles in a patient with wolff-Parkinson-White syndrome (type B). Circulation. 1967;35:15–21.
Kottkamp H, Hindricks G, Breithardt G, Borggrefe M. Three-dimensional electromagnetic catheter technology: electroanatomical mapping of the right atrium and ablation of ectopic atrial tachycardia. J Cardiovasc Electrophysiol. 1997;8:1332–7.
doi: 10.1111/j.1540-8167.1997.tb01029.x
Shah DC, Jaïs P, Haïssaguerre M, Chouairi S, Takahashi A, Hocini M, et al. Three-dimensional mapping of the common atrial flutter circuit in the right atrium. Circulation. 1997;96:3904–12.
doi: 10.1161/01.CIR.96.11.3904
Takigawa M, Derval N, Frontera A, Martin R, Yamashita S, Cheniti G, et al. Revisiting anatomic macroreentrant tachycardia after atrial fibrillation ablation using ultrahigh-resolution mapping: implications for ablation. Heart Rhythm. 2018;15:326–33.
doi: 10.1016/j.hrthm.2017.10.029
Scherr D, Khairy P, Miyazaki S, Aurillac-Lavignolle V, Pascale P, Wilton SB, et al. Five-Year Outcome of Catheter Ablation of Persistent Atrial Fibrillation Using Termination of Atrial Fibrillation as a Procedural Endpoint. Circ-Arrhythmia Elec 205;8:18–24.
Frontera A, Mahajan R, Dallet C, Vlachos K, Kitamura T, Cheniti G, et al. Characterizing localised reentry with high resolution mapping: evidence for multiple slow conducting isthmuses within the circuit. Heart Rhythm. 2018 [cited 2018 Dec 8];0. Available from: https://www.heartrhythmjournal.com/article/S1547-5271(18)31172-X/abstract .
Williams SE, Harrison JL, Chubb H, Whitaker J, Kiedrowicz R, Rinaldi CA, et al. Local activation time sampling density for atrial tachycardia contact mapping: how much is enough? Europace. 2018;20:e11–20.
doi: 10.1093/europace/eux037
Olshansky B, Okumura K, Henthorn RW, Waldo AL. Characterization of double potentials in human atrial flutter: studies during transient entrainment. J Am Coll Cardiol. 1990;15:833–41.
doi: 10.1016/0735-1097(90)90283-U
Tada H, Oral H, Sticherling C, Chough SP, Baker RL, Wasmer K, et al. Double potentials along the ablation line as a guide to radiofrequency ablation of typical atrial flutter. J Am Coll Cardiol. 2001;38:750–5.
doi: 10.1016/S0735-1097(01)01425-5
Morgan JM, Haywood G, Schirdewan A, Brugada P, Geelen P, Meyerfeldt U, et al. “Double” potentials define linear lesion conduction block using a novel mapping/linear lesion ablation catheter. J Cardiovasc Electrophysiol. 2003;14:236–42.
doi: 10.1046/j.1540-8167.2003.02400.x
Winkle RA, Moskovitz R, Mead RH, Engel G, Kong MH, Fleming W, et al. Ablation of atypical atrial flutters using ultra high density-activation sequence mapping. J Interv Card Electrophysiol. 2017;48:177–84.
doi: 10.1007/s10840-016-0207-5
Coffey JO, d’Avila A, Dukkipati S, Danik SB, Gangireddy SR, Koruth JS, et al. Catheter ablation of scar-related atypical atrial flutter. Europace. 2013;15:414–9.
doi: 10.1093/europace/eus312
Latcu DG, Squara F, Massaad Y, Bun S-S, Saoudi N, Marchlinski FE. Electroanatomic characteristics of the mitral isthmus associated with successful mitral isthmus ablation. Europace. 2016;18:274–80.
doi: 10.1093/europace/euv097

Auteurs

Grégoire Massoullié (G)

Cardiology Department, CHU Clermont-Ferrand, Clermont University, ISIT-CaVITI, 58 rue Montalembert, 63000 CHU, Clermont-Ferrand, France. gmassoullie@chu-clermontferrand.fr.

Ghassan Moubarak (G)

Department of Electrophysiology and Pacing, Centre Médico-Chirurgical Ambroise Paré, Neuilly-sur-Seine, France.

Olivier Thomas (O)

Department of Electrophysiology and Pacing, Centre Médico-Chirurgical Ambroise Paré, Neuilly-sur-Seine, France.

Antoine Da Costa (A)

Division of Cardiology, Jean Monnet University, Saint-Etienne, France.

Vincent Roger (V)

Biosense Webster, Issy-les-Moulineaux, France.

Julio Justo (J)

Royal Sussex County Hospital, Brighton, UK.

Alexis Mechulan (A)

Department of Cardiology, CH Clairval, Marseille, France.

Romain Eschalier (R)

Cardiology Department, CHU Clermont-Ferrand, Clermont University, ISIT-CaVITI, 58 rue Montalembert, 63000 CHU, Clermont-Ferrand, France.

John Silberbauer (J)

Royal Sussex County Hospital, Brighton, UK.

Marius Andronache (M)

Cardiology Department, CHU Clermont-Ferrand, Clermont University, ISIT-CaVITI, 58 rue Montalembert, 63000 CHU, Clermont-Ferrand, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH